Home

"TLA is a highly efficient method for mapping the insertion site of any transgene.”

Genentech
Dr. Søren Warming - Associate Director/Senior Scientist

"Targeted Locus Amplification enables fast identification of new chromosomal rearrangements and genomic breakpoint sequences in human T-ALL and unraveled a higher complexity of chromosomal translocations of known T-ALL oncogenes as thus far appreciated.”

Ghent University
Prof. Dr. Pieter van Vlierberghe - Center for Medical Genetics

"We use TLA to sequence gene fusions and other rearrangements in genes of interest. We have been impressed by the quality of TLA and Cergentis' work and are testing the use of identified breakpoint sequences as targets for personalised minimal residual disease tests."

Princess Máxima Center for Pediatric Oncology
Dr. Roland Kuiper - PI
  • Latest news

  • Empowering advanced genetic engineering
    &
    precision medicine

  • Upcoming events

  • APPNOTES

    Read more
  • TLA technology

    Read more
  • Publications

    Read more
© 2012-2021 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.
ACCEPT